Nature3 min read
Moderna mRNA vaccine almost halves the risk of skin cancer returning
Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.
By Mohana BasuNature AI

Read the full story
Originally published by Nature AI on Oct 23, 2026.
Comments
Sign in to join the discussion.